An immune system cell comprising a chimeric cytokine receptor comprising a cytokine-binding exodomain and a signal transducing endodomain, wherein (a) the exodomain comprises an IL-13 cytokine binding exodomain and an IL-15 signal transducing endodomain. Further discloses treatment of cancer.